To include your compound in the COVID-19 Resource Center, submit it here.

Intratumor bacteria could confer resistance to gemcitabine

In a paper published in Science, researchers at the Weizmann Institute of Science and colleagues showed that intratumor bacteria can metabolize the chemotherapeutic drug gemcitabine, inducing tumor

Read the full 275 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE